Solid Tumors
A Phase 2 multi-center open-label basket trial of nab-sirolimus for adult and adolescent patients with malignant solid tumors harboring pathogenic inactivating alterations in TSC1 or TSC2 genes (TSC-007)
- Details
ClinicalTrials.gov ID:
NCT05103358
Diagnosis Type:
NA
USOR Number:
- Address
22 W Dry Creek Circle
Littleton, CO 80120
P: (303) 730-4700